CSIMarket Company Name, Ticker, Industry, else..


Iradimed Corporation  (NASDAQ: IRMD)
Other Ticker:  
 

Iradimed Corporation

IRMD's Fundamental analysis



Looking into Iradimed growth rates, revenue grew by 10.87 % in the first quarter of 2025 from the same quarter a year ago. Ranking at No. 813

Medical Equipment & Supplies industry recorded deterioration of revenues by -0.36 %

Iradimed's net income grew by 13.32 % in first quarter of 2025 year on year, above company average,

• More on IRMD's Growth


Iradimed
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Iradimed PEG ratio is at 2.3 Company is currently trading with Price to Cash flow multiple of 152.3 in trailing twelve-month period.
Company
39.89
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 10.55.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.22.


• More on IRMD's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0.62 $
 Dividend Yield TTM (%) 1.1 %
 Revenue/Employee (TTM) $ 507,802
 Net Income/Employee (TTM) $ 133,682
 Receivable Turnover (TTM) 6.6
 Tangible Book Value (Per Share $) 6.77

Iradimed
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Iradimed PEG ratio is at 2.3 Company is currently trading with Price to Cash flow multiple of 152.3 in trailing twelve-month period.
Company
39.89
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 10.55.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.22.

Iradimed Price to Book Ratio is at 8.8 higher than Industry Avg. of -588.92, and higher than S&P 500 Avg. of 0.01

• More on IRMD's Valuation

•  Market Capitalization (Millions $) 793
•  Shares Outstanding (Millions) 13
•  Employees 148
•  Revenues (TTM) (Millions $) 75
•  Net Income (TTM) (Millions $) 20
•  Cash Flow (TTM) (Millions $) 5
•  Capital Exp. (TTM) (Millions $) -12
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0.62 $
•  Dividend Yield TTM (%) 1.1 %
•  Revenue/Employee (TTM) $ 507,802
•  Net Income/Employee(TTM) $ 133,682
•  Receivable Turnover Ratio (TTM) 6.6
•  Tangible Book Value (Per Share $) 6.77

•  Market Capitalization (Millions $) 793
•  Shares Outstanding (Millions) 13
•  Employees 148
•  Revenues (TTM) (Millions $) 75
•  Net Income (TTM) (Millions $) 20
•  Cash Flow (TTM) (Millions $) 5
•  Capital Exp. (TTM) (Millions $) -12


    IRMD's Profitability Comparisons
Iradimed faced margin deterioration, primarily through cost pressure. Operating Margin fell in first quarter of 2025 to 27.84 % from 29.91 % in IV. Quarter.

Iradimed net profit margin of 24.02 % is currently ranking no. 10 in Medical Equipment & Supplies industry, ranking no. 47 in Healthcare sector and number 568 in S&P 500.


Profitability by Segment
Total 24.02 %



  Ratio
•   Capital Ratio (MRQ) 8.87
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.13
•  Asset Turnover Ratio (TTM) 0.79
•  Inventory Turnover Ratio (TTM) 1.57



Iradimed faced margin deterioration, primarily through cost pressure. Operating Margin fell in first quarter of 2025 to 27.84 % from 29.91 % in IV. Quarter.

Iradimed net profit margin of 24.02 % is currently ranking no. 10 in Medical Equipment & Supplies industry, ranking no. 47 in Healthcare sector and number 568 in S&P 500.

• More on IRMD's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com